Literature DB >> 29045243

Use of Ketamine in a Multimodal Analgesia Setting for Rapid Opioid Tapering in a Profoundly Opioid-Tolerant Patient: A Case Report.

Elise M Strickler1, Eric S Schwenk, Mitchell J Cohen, Eugene R Viscusi.   

Abstract

Opioids are frequently used for the treatment of chronic pain, and patients taking high doses are at increased risk of complications and adverse opioid-related events. Ketamine is appealing as an opioid adjunct because of its lack of respiratory depression and potential prevention of hyperalgesia and central sensitization. We present a case in which a ketamine infusion was utilized over a 7-day period to provide rapid taper of a daily dose of 400 mg of morphine equivalents to less than one-third of that dose on discharge with unchanged pain levels and no symptoms of opioid withdrawal.

Entities:  

Year:  2018        PMID: 29045243     DOI: 10.1213/XAA.0000000000000653

Source DB:  PubMed          Journal:  A A Pract        ISSN: 2575-3126


  3 in total

Review 1.  Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence.

Authors:  Kelly E Dunn; Andrew S Huhn; Cecilia L Bergeria; Cassandra D Gipson; Elise M Weerts
Journal:  J Pharmacol Exp Ther       Date:  2019-08-07       Impact factor: 4.030

2.  Ketamine as an Analgesic Adjunct for Opioid-Induced Hyperalgesia in a Patient With a Sickle Cell Pain Episode.

Authors:  Michael R Martinez; Emily H Garmon; Garrett D Starling; Monish A Sheth
Journal:  Ochsner J       Date:  2022

Review 3.  Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review.

Authors:  Jennifer L Jones; Camilo F Mateus; Robert J Malcolm; Kathleen T Brady; Sudie E Back
Journal:  Front Psychiatry       Date:  2018-07-24       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.